Skip to main content
Signal8

Alfieri Michael

SEC insider (Form 3/4/5 filer). CIK 0001744687. Principal Financial Officer at Aldeyra Therapeutics, Inc. (ALDX). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 18, 2026. Located in LEXINGTON, MA.

Companies Alfieri Michael has filed insider reports for

  • Aldeyra Therapeutics, Inc. (ALDX): Officer, Principal Financial Officer
Alfieri Michael profile photo

Alfieri Michael

CIK: 0001744687

Transaction Breakdown

Open Market Buys (P)2 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aldeyra Therapeutics, Inc. logo
ALDX

Aldeyra Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Aldeyra Therapeutics, Inc. logo
    ALDX

    Aldeyra Therapeutics, Inc.

    Mar 18, 2026
    Purchase
    Direct
    5K shares at avg. $1.42$7K
  • Aldeyra Therapeutics, Inc. logo
    ALDX

    Aldeyra Therapeutics, Inc.

    Aug 13, 2025
    Purchase
    Direct
    2.5K shares at avg. $5.30$13K

1-2 of 2